Sorry not to come back to you, 10 is way past mine lol and there was the matter of ghostlys post re SCLP. It is wrong to talk sclp here even worse for his disgusting posts, boomorbust invited him over to debate to no avail as ever.
The simple answer is my friend is it will do so much for this share and the credibility..........but we know that. Glad to see folks talking about a T/O but i cant discuss posts like £500m will be turned down for my reasons. We have researched long and hard the competitors and prices of deals on another share, i dont see that done here.
Might i suggest rather than saying others get bought without data perhaps folk can give examples relative to this field and explain any other company that has gone from £8m m/cap---£500m in weeks, and its not enough!!!! You are far Better researched here than me please can you post who your nearest competitors are so we can debate further and why VAL are worth more. ATB
No its not Bla bla obilex its all good and a very good estimate, its about time we started highlighting the potential here we've been to quite for to long sort of unsure how things were going to pan out, but the last few weeks have proved the BOD are making exceptional advances and we are now at the point where we will witness rapid progress.
I believe if any TO happens here We will have a bid near to 15p (my opinion) VAL201 worth £750 millions according to DS. VAL101 & GeneIce and VAL401 We don't know yet any value. I can be wrong as well, Pharma Industry it's Worldwide Business not only local. If We all thing about Global Market, I'm really sure VAL will be in different level next year, as they have someone to look at this deal or deals next year. Maybe my words it's pure bla bla bla or maybe I'm right about it. Only time will tell Mate. Obelix
There is off course an other issue that so far the loyal members of the board have been to polite to discuss, so I thought having been branded Mr nasty, discussing, foul mouthed Ect. Ect. I feel well qualified to broach the subject.
Which is, that with at least five years research behind us and four potential world beating products in or about to enter trials under the protection of virtually all the required patents in place, we now have a tangible value as a take over target a little fact that the market has also chosen to turn a blind eye to, I’m not sure how much it would cost a large phama to develop these products and secure the patents if they started out today but I suspect on all four products we would be looking at five years minimum and at least £100m, the big problem for them is they can never do it because we own the patents.
So how much are we worth just as a take over. 5p 10p 20p ? I don’t know but I sure would be interested to know what you all think.
Multi I love your positive posts, But one very important issue I feel would underpin your summary and add a powerful endorsement would be for you to mention that the science is cutting edge "of the time" it a "right here right now" and not something that has been peddled on the market for over a year with little interest, the other thing is there is nothing out there that is better or as far advanced that we are aware of and as Satu has said the big payers no what the science is, you bet they want it, the question is how much are they willing to pay. Oh and I'm not talking one product its four products, with at least one of them having the potential to be a treatment for multiple conditions, the phamas are lining up mate cheque books in hand none of them will be willing to miss this opportunity. Good luck keep up your fantastic work.
Do you mind me asking you to answer the question of what do you think happens if a corporate deal is done for 101. Let's assume it is and it represents funding for clinical development of 101 with of course the link to GeneICE. What's your view on what that would do for credibility of the company, the science, etc? Also for the MCAP? Also does it send a message to the industry essentially stating we are Valirx we have just done a deal, so actually those looking at our other compounds, 201, 401, etc better look now and do a deal sooner than later or risk losing out to a competitor?
I of course accept there is an element of risk v reward in investing, there is of course risk with Valirx though my view is as you know bullish that a deal is very close and we are in the timeframes suggested. This is of course on top of 201 dosing, 401 progressing to clinical application and bio markers. Hence why I think it is such a strong buy.
Very interested in your views of what happens if the company secure a deal? As outlined above.
The current low sp sure is a golden opportunity to buy in or top up boys and girls...I m filling my boots good and proper here. at this price Good luck all, there are going to be a lot of wealthy investors here in the not too distant...:-)
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.